Operating Lease, Right-of-Use Asset of Cytosorbents Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cytosorbents Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Cytosorbents Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11,075,000, a 4.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cytosorbents Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,075,000 -$576,563 -4.9% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $11,223,000 -$566,539 -4.8% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $11,368,340 -$556,959 -4.7% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $11,511,000 -$547,896 -4.5% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $11,651,563 -$544,486 -4.5% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $11,789,539 -$544,431 -4.4% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $11,925,299 -$544,606 -4.4% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $12,058,896 -$545,005 -4.3% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $12,196,049 -$598,291 -4.7% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $12,333,970 -$647,704 -5% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $12,469,905 -$726,890 -5.5% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $12,603,901 -$819,571 -6.1% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $12,794,340 -$857,277 -6.3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $12,981,674 -$281,857 -2.1% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $13,196,795 +$12,272,835 +1328% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $13,423,472 +$12,394,349 +1204% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $13,651,617 +$12,519,702 +1106% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $13,263,531 +$12,031,143 +976% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $923,960 -$46,222 -4.8% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $1,029,123 -$41,639 -3.9% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $1,131,915 -$37,160 -3.2% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $1,232,388 -$32,782 -2.6% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $970,182 -$388,915 -29% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $1,070,762 -$378,675 -26% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $1,169,075 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $1,265,170 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $1,359,097 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $1,449,437 31 Dec 2018 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.